ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 239 filers reported holding ARRAY BIOPHARMA INC in Q4 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $27,469,000 | +572.8% | 592,903 | +254.0% | 0.03% | +550.0% |
| Q1 2019 | $4,083,000 | +68.5% | 167,494 | -2.1% | 0.00% | +33.3% |
| Q4 2018 | $2,423,000 | -8.8% | 171,034 | -2.1% | 0.00% | +50.0% |
| Q3 2018 | $2,656,000 | -50.3% | 174,725 | -45.2% | 0.00% | -60.0% |
| Q2 2018 | $5,349,000 | -9.0% | 318,770 | -11.5% | 0.01% | -16.7% |
| Q1 2018 | $5,876,000 | +17.7% | 360,015 | -7.7% | 0.01% | +50.0% |
| Q4 2017 | $4,992,000 | +7.7% | 389,985 | +3.4% | 0.00% | 0.0% |
| Q3 2017 | $4,637,000 | +330.5% | 377,000 | +59.6% | 0.00% | +300.0% |
| Q2 2014 | $1,077,000 | -3.6% | 236,277 | -0.6% | 0.00% | 0.0% |
| Q1 2014 | $1,117,000 | -11.6% | 237,602 | -5.7% | 0.00% | -50.0% |
| Q4 2013 | $1,263,000 | -24.0% | 252,031 | -5.6% | 0.00% | 0.0% |
| Q3 2013 | $1,661,000 | – | 267,060 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 15,978,580 | $268,121,000 | 9.11% |
| BVF INC/IL | 4,672,195 | $78,399,000 | 7.65% |
| First Light Asset Management, LLC | 2,391,575 | $40,131,000 | 6.25% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 694,500 | $11,647,000 | 4.47% |
| Copernicus Capital Management, LLC | 286,797 | $4,812,000 | 3.49% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 225,511 | $3,784,000 | 3.00% |
| SECTORAL ASSET MANAGEMENT INC | 1,566,477 | $26,285,000 | 2.94% |
| X-Square Capital, LLC | 173,802 | $2,917,000 | 2.18% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 2,618,654 | $43,941,000 | 1.48% |
| Birchview Capital, LP | 128,000 | $2,148,000 | 1.46% |